Leerink Swann Weighs in on Incyte Corporation's Q3 2017 Earnings (INCY)

Lloyd Doyle
October 13, 2017

LLC now owns 457,455 shares of the biopharmaceutical company's stock worth $57,598,000 after purchasing an additional 132,127 shares during the period. The Jgp Global Gestao De Recursos Ltda holds 23,300 shares with $2.93M value, up from 15,188 last quarter. Telus Corp now has $21.29B valuation. The stock is now trading -0.21% away from the 52-week high and separated 60.54% from the 52-week low. The company's market cap is $24.07 Billion, and the average volume is 1.45 Million. CONSOL Energy Inc. (NYSE:CNX) has risen 22.10% since October 12, 2016 and is uptrending. It has outperformed by 13.33% the S&P500. Recently, shares of Incyte Corporation (NASDAQ:INCY) have been seen trading -11.37% away from the 200-day moving average and -8.87% off the 50-day moving average. The Matrix Capital Management Company Lp holds 1.80M shares with $226.23M value, up from 1.40M last quarter. Wfg Advisors LP invested in 1,983 shares or 0.06% of the stock.

VIVUS, Inc. (NASDAQ:VVUS)'s latest quote $0.86 $-3.15 -2.75% will find technical support in $0.84 a share and a breakdown below this region would be a significantly bearish signal for VIVUS, Inc. traders.

Incyte Corporation (NASDAQ:INCY) last announced its quarterly earnings data on Tuesday, August 1st. It has outperformed by 56.14% the S&P500.

Among 16 analysts covering Consol Energy Inc. RBC Capital Markets has "Outperform" rating and $46.0 target.

Analysts await TELUS Corporation (USA) (NYSE:TU) to report earnings on November, 3. The rating was initiated by Susquehanna on Friday, October 30 with "Neutral". On Sunday, June 4 the stock rating was maintained by Cowen & Co with "Buy". The biopharmaceutical company reported ($0.96) earnings per share for the quarter, beating the Zacks' consensus estimate of ($0.97) by $0.01. The firm has "Buy" rating by Stifel Nicolaus given on Thursday, August 24. The rating was maintained by Argus Research on Monday, September 26 with "Buy". The stock has "Buy" rating by Jefferies on Wednesday, July 27. The stock of Incyte Corporation (NASDAQ:INCY) has "Outperform" rating given on Monday, January 23 by Credit Suisse. Argent Trust Co owns 5,460 shares. Bridgeway Incorporated has invested 0% in SKY PLC (LON:SKY). Leerink Swann also issued estimates for Incyte Corporation's FY2018 earnings at $0.52 EPS, FY2019 earnings at $1.47 EPS and FY2020 earnings at $3.08 EPS. 28 funds opened positions while 84 raised stakes. In that case, its shares would mark a 2.06% decline from the most recent price. (NYSE:CNX) for 5,100 shares. Tower Rech (Trc) holds 0% or 1,983 shares. Gardner Lewis Asset Management LP sold 11,618 shares as Incyte Corp. Rock Springs Cap Mngmt Limited Partnership holds 1.1% or 173,000 shares.


Rockwell Automation Inc. (NYSE:ROK) moved 0.55% from the recent close and now pricing at $183.75. Morgan Stanley invested in 0.02% or 470,337 shares. Bankshares Of Ny Mellon reported 0.01% of its portfolio in CONSOL Energy Inc. On Monday, May 1 the insider Flannelly Barry P sold $660,564. On Friday, April 28 the insider GRYSKA DAVID W sold $172,597. Over the last three months, insiders acquired 3,000 shares of company stock valued at $398,770 and sold 137,968 shares valued at $19,395,245. Siegel Eric H. sold $227,009 worth of stock. Eqis Capital Management Inc. increased its position in shares of Incyte Corporation by 8.3% during the 3rd quarter. Seven analysts have rated the stock with a hold rating, eighteen have given a buy rating and one has given a strong buy rating to the stock. Therefore 70% are positive. Incyte had 67 analyst reports since August 6, 2015 according to SRatingsIntel. The firm earned "Overweight" rating on Tuesday, August 18 by Piper Jaffray.

Incyte Corporation (INCY) now has a Return on Assets (ROA) value of -9.6 Percent. The stock of Incyte Corporation (NASDAQ:INCY) has "Buy" rating given on Friday, July 21 by BMO Capital Markets. Incyte Corporation now has a consensus rating of "Buy" and an average price target of $144.84. The company was maintained on Tuesday, June 6 by Oppenheimer. Gabelli restated a "buy" rating and issued a $174.00 price objective on shares of Incyte Corporation in a research report on Wednesday, June 28th. Since an alpha above 1 hints at more gains, investors can predict some further rally scope. Its up 0.08, from 1.67 in 2017Q1. It increased, as 60 investors sold CELG shares while 390 reduced holdings.

16 analysts on average are expecting the company to report revenue of $402.86 Million for the current quarter. BIENAIME JEAN JACQUES also bought $57,500 worth of Incyte Corporation (NASDAQ:INCY) shares. (NASDAQ:VVUS) higher to the next line of resistance at $0.91 a share. Howard Hughes Med Institute has invested 0.02% in Incyte Corporation (NASDAQ:INCY). Dupont Cap Management Corporation owns 8,998 shares or 0.03% of their United States portfolio. Susquehanna Intll Grp Llp, Pennsylvania-based fund reported 35,760 shares.

Gardner Lewis Asset Management LP decreased Incyte Corp. Baker Bros Advsr Lp accumulated 37.57% or 34.13 million shares. The stock of Incyte Corporation (NASDAQ:INCY) earned "Hold" rating by Oppenheimer on Tuesday, August 1. If VIVUS, Inc. (NASDAQ:VVUS) shares can stay above the price resistance around $0.88 a share, that could help propel VIVUS, Inc.

Other reports by Iphone Fresh

Discuss This Article

FOLLOW OUR NEWSPAPER